CNBC US Markets12.05.2026PolitikUnited States
FDA Commissioner Dr. Marty Makary Resigns Amid Controversy
Makary's tenure marked by internal dysfunction and regulatory backlash
Auf einen Blick
Dr. Marty Makary resigned as FDA commissioner amid controversy and internal dysfunction, to be replaced by Kyle Diamantas as acting commissioner
KI-generierte Zusammenfassung
Schriftgröße
Dr. Marty Makary resigned as FDA commissioner amid controversy and internal dysfunction, to be replaced by Kyle Diamantas as acting commissioner
Verwandte Themen
This article was originally published by CNBC US Markets.
